Woke Pharmaceuticals

An Australian biotech company developing proprietary synthetic psilocybin formulations and novel psychedelic therapies for mental health disorders. Woke Pharmaceuticals sponsors clinical trials for treatment-resistant depression partnering with leading universities including Swinburne University and the University of Western Australia, and is developing novel LSD analogues through research collaboration aimed at improving therapeutic profiles.